Radiopharmaceuticals company Telix Pharmaceuticals has provided its Q4 FY24 trading update, showing sustained revenue growth.
Shanghai Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel ...
IMPACT Therapeutics ('IMPACT'), a biopharmaceutical company focusing on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality, is pleased to announce that ...
Little pouches of nicotine sold by the brand ZYN were given the green light for marketing this week through the U.S. Food and ...
Unusual Machines, Inc. (NYSE American:UMAC), a leading innovator in drone technology with a current focus on U.S. based manufacturing and marketing of drone parts is pleased to announce the release of ...
The U.S. Food and Drug Administration (FDA) today authorized ZYN nicotine pouches making ZYN the first and only authorized nicoti ...
InflaRx receives European marketing authorization for Gohibicto treat of SARS-CoV-2-induced acute respiratory distress syndrome: Jena, Germany Friday, January 17, 2025, 11:00 Hrs ...
Telix’s lead imaging product, gallium-68 ( 68 Ga) gozetotide injection (also known as 68 Ga PSMA-11 and marketed under the brand name Illuccix®), has been approved by the U.S. Food and Drug ...
ORLANDO, FLORIDA / ACCESS Newswire / January 17, 2025 / Unusual Machines, Inc. (NYSE American:UMAC), a leading innovator in drone technology with a current focus on U.S. based manufacturing and market ...
The U.S. Food and Drug Administration has authorized all ZYN Nicotine Pouch Products Currently Marketed by Swedish Match, a ...
The ASX200 closed down 0.2% at 8,310 points. China’s latest economic data beat estimates. GDP growth accelerated to 5.4 per ...
Orchid Security, an emerging leader in identity-first security orchestration, announced it has raised $36 million in seed funding, enabling the company to continue its work using Large Language Models ...